Literature DB >> 21352372

Evaluation of the 6-minute walk test in pet dogs.

R A Swimmer1, E A Rozanski.   

Abstract

BACKGROUND: The 6-minute walk test (6MWT) is widely used in human medicine to objectively assess the degree of impairment, and to provide objective evidence of disease progression or response to therapy. HYPOTHESIS/
OBJECTIVES: The 6MWT will be easy to perform and well-tolerated in pet dogs. Dogs with pulmonary disease will walk shorter distances than healthy dogs. ANIMALS: Sixty-nine healthy dogs were recruited from the hospital community. Six dogs with mild to moderate pulmonary disease were recruited from animals presented for evaluation at the teaching hospital.
METHODS: Prospective study. Dogs walked for 6 minutes in a hallway and the distance covered was measured. Pulse oximetry and heart rate were recorded before and after walking. Physical characteristics of the dogs, including age, leg length, body condition score, and weight, were recorded. Healthy dogs were compared with affected dogs by a Student's t-test (P < .05). Correlations were calculated between the age, physical characteristics, and distances walked in the healthy dogs.
RESULTS: Healthy dogs walked 522.7 ± 52.4 m, while sick dogs (n = 6) walked 384.8 ± 41.0 m (P < .001). There was low (r = 0.13) to moderate (r= 0.27) correlation in the healthy dogs between physical characteristics and distances walked. CONCLUSIONS AND CLINICAL IMPORTANCE: The 6MWT was easy to perform and discriminated between healthy dogs and dogs with pulmonary disease.
Copyright © 2011 by the American College of Veterinary Internal Medicine.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21352372      PMCID: PMC3052904          DOI: 10.1111/j.1939-1676.2011.0689.x

Source DB:  PubMed          Journal:  J Vet Intern Med        ISSN: 0891-6640            Impact factor:   3.333


  10 in total

1.  The 6-minute walk test: normal values for children of 4-11 years of age.

Authors:  A E Lammers; A A Hislop; Y Flynn; S G Haworth
Journal:  Arch Dis Child       Date:  2007-08-03       Impact factor: 3.791

Review 2.  Six minute corridor walk test as an outcome measure for the assessment of treatment in randomized, blinded intervention trials of chronic heart failure: a systematic review.

Authors:  Lars G Olsson; Karl Swedberg; Andrew L Clark; Klaus K Witte; John G F Cleland
Journal:  Eur Heart J       Date:  2005-03-17       Impact factor: 29.983

Review 3.  Airway physiology and clinical function testing.

Authors:  Andrew M Hoffman
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-09       Impact factor: 2.093

Review 4.  Field tests of exercise in COPD: the six-minute walk test and the shuttle walk test.

Authors:  Cynthia D Brown; Robert A Wise
Journal:  COPD       Date:  2007-09       Impact factor: 2.409

5.  Clinical determinants of the 6-Minute Walk Test in bronchiectasis.

Authors:  A L Lee; B M Button; S Ellis; R Stirling; J W Wilson; A E Holland; L Denehy
Journal:  Respir Med       Date:  2008-12-12       Impact factor: 3.415

6.  Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients.

Authors:  Wander O Villalba; Percival D Sampaio-Barros; Mônica C Pereira; Elza M F P Cerqueira; Cid A Leme; João F Marques-Neto; Ilma A Paschoal
Journal:  Chest       Date:  2007-01       Impact factor: 9.410

7.  Time to desaturation in the 6-min walking distance test predicts 24-hour oximetry in COPD patients with a PO2 between 60 and 70mmHg.

Authors:  Ignacio García-Talavera; Concepción Hernández García; Ciro Casanova Macario; Juan Pablo de Torres; Bartolomé R Celli; Armando Aguirre-Jaime
Journal:  Respir Med       Date:  2008-03-17       Impact factor: 3.415

8.  Walking distance on 6-MWT is a prognostic factor in idiopathic pulmonary fibrosis.

Authors:  Antonella Caminati; Achille Bianchi; Roberto Cassandro; Maria Rosa Mirenda; Sergio Harari
Journal:  Respir Med       Date:  2008-09-10       Impact factor: 3.415

Review 9.  The six-minute walk test.

Authors:  Paul L Enright
Journal:  Respir Care       Date:  2003-08       Impact factor: 2.258

10.  Evaluation of the six-minute walk test in dogs.

Authors:  Kirstin N Boddy; Brian M Roche; Denise S Schwartz; Tomohiro Nakayama; Robert L Hamlin
Journal:  Am J Vet Res       Date:  2004-03       Impact factor: 1.156

  10 in total
  13 in total

Review 1.  Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials.

Authors:  Joe N Kornegay; Christopher F Spurney; Peter P Nghiem; Candice L Brinkmeyer-Langford; Eric P Hoffman; Kanneboyina Nagaraju
Journal:  ILAR J       Date:  2014

2.  Global positioning system derived performance measures are responsive indicators of physical activity, disease and the success of clinical treatments in domestic dogs.

Authors:  Elizabeth A Bruno; James W Guthrie; Stephen A Ellwood; Richard J Mellanby; Dylan N Clements
Journal:  PLoS One       Date:  2015-02-18       Impact factor: 3.240

3.  Long-term outcome and use of 6-minute walk test in West Highland White Terriers with idiopathic pulmonary fibrosis.

Authors:  L I O Lilja-Maula; H P Laurila; P Syrjä; A K Lappalainen; E Krafft; C Clercx; M M Rajamäki
Journal:  J Vet Intern Med       Date:  2014-01-13       Impact factor: 3.333

4.  Effect of body weight loss on cardiopulmonary function assessed by 6-minute walk test and arterial blood gas analysis in obese dogs.

Authors:  J Manens; R Ricci; C Damoiseaux; S Gault; B Contiero; M Diez; C Clercx
Journal:  J Vet Intern Med       Date:  2013-12-18       Impact factor: 3.333

5.  Noninvasive Assessment of Neuromuscular Disease in Dogs: Use of the 6-minute Walk Test to Assess Submaximal Exercise Tolerance in Dogs with Centronuclear Myopathy.

Authors:  S Cerda-Gonzalez; L Talarico; R Todhunter
Journal:  J Vet Intern Med       Date:  2016-03-25       Impact factor: 3.333

6.  Evaluation of Thermographic Imaging in Canine Hindlimb Muscles After 6 Min of Walking-A Pilot Study.

Authors:  Jennifer Repac; Leilani X Alvarez; Ken Lamb; Robert L Gillette
Journal:  Front Vet Sci       Date:  2020-04-30

7.  Breeding French bulldogs so that they breathe well-A long way to go.

Authors:  Eva-Marie Ravn-Mølby; Line Sindahl; Søren Saxmose Nielsen; Camilla S Bruun; Peter Sandøe; Merete Fredholm
Journal:  PLoS One       Date:  2019-12-16       Impact factor: 3.240

8.  Fluoroscopic Estimation of Thoracic Dimensional Changes in Healthy Dogs.

Authors:  J C Chan; L R Johnson; C S Brown; R E Pollard
Journal:  J Vet Intern Med       Date:  2017-09-29       Impact factor: 3.333

9.  Effect of Body Position, Exercise, and Sedation on Estimation of Pulmonary Artery Pressure in Dogs with Degenerative Atrioventricular Valve Disease.

Authors:  J D Rhinehart; K E Schober; B A Scansen; V Yildiz; J D Bonagura
Journal:  J Vet Intern Med       Date:  2017-09-02       Impact factor: 3.333

10.  Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly.

Authors:  Nayeli Iwanuk; Leona Wall; Ingo Nolte; Jonathan Raue; Katja Rumstedt; Anna Pilgram; Maximiliane Sehn; Karl Rohn; Jan-Peter Bach
Journal:  PLoS One       Date:  2019-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.